Literature DB >> 2437150

Antibodies to various bacterial cell wall peptidoglycans in human and rabbit sera.

H I Wergeland, C Endresen.   

Abstract

Sera from patients with verified systemic staphylococcal infection contained antibodies reactive with peptidoglycan (PG) from Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Micrococcus lysodeikticus, Bacillus subtilis, and Escherichia coli. The presence of anti-PG cross-reactive antibodies was verified in patient sera by inhibition studies with the various bacterial PGs. Antibodies to nonstaphylococcal PGs were also elevated in sera from rabbits immunized with S. aureus PG. Antibodies to S. aureus PG were removed with the synthetic peptide analogs of S. aureus PG, the L-Lys-D-Ala-D-Ala, L-Lys-D-Ala, and (Gly)5 determinants, as well as with an S. aureus PG peptide fragment containing the determinants D-Ala-D-Ala and L-Lys-D-Ala. Isolated antibodies to the PG peptides, both synthetic and native, were reactive with S. aureus and S. epidermidis PGs. The antibodies to the D-Ala-D-Ala and the L-Lys-D-Ala determinants were also reactive with S. pyogenes PG, but not with PGs from M. lysodeikticus, B. subtilis, and E. coli.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437150      PMCID: PMC265983          DOI: 10.1128/jcm.25.3.540-545.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  A fractionation procedure for studies of the synthesis of cell-wall mucopeptide and of other polymers in cells of Staphylococcus aureus.

Authors:  J T PARK; R HANCOCK
Journal:  J Gen Microbiol       Date:  1960-02

Review 2.  Immunological properties of teichoic acids.

Authors:  K W Knox; A J Wicken
Journal:  Bacteriol Rev       Date:  1973-06

3.  Immunochemical characterization of staphylococcal and microbial mucopeptides.

Authors:  S M Helgeland; A Grov
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  The immunochemistry of peptidoglycan. I. The immunodominant site of the peptide subunit and the contribution of each of the amino acids to the binding properties of the peptides.

Authors:  K H Schleifer; R M Krause
Journal:  J Biol Chem       Date:  1971-02-25       Impact factor: 5.157

5.  Studies on antigen preparations from Staphylococcus aureus. 8. The substance of crude protein A sensitizing tanned erythrocytes.

Authors:  A Grov
Journal:  Acta Pathol Microbiol Scand       Date:  1969

6.  An immunochemical analysis of bacterial mucopeptides.

Authors:  W W Karakawa; H Lackland; M Krause
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

7.  The role of D-alanine in the antigenic specificity of bacterial mucopeptides.

Authors:  W W Karakawa; P H Maurer; P Walsh; R M Krause
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

8.  Antimucopeptide antibodies and their specificity.

Authors:  M Rolicka; J T Park
Journal:  J Immunol       Date:  1969-08       Impact factor: 5.422

9.  The immunochemistry of peptidoglycan. Separation and characterization of antibodies to the glycan and to the peptide subunit.

Authors:  K H Schleifer; R M Krause
Journal:  Eur J Biochem       Date:  1971-04-30

10.  Immunochemical studies on the cross-reactivity between streptococcal and staphylococcal mucopeptide.

Authors:  W W Karakawa; D G Braun; H Lackland; R M Krause
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

View more
  7 in total

1.  Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections.

Authors:  H I Wergeland; L R Haaheim; O B Natås; F Wesenberg; P Oeding
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

2.  Production and characterization of a monoclonal antibody to the O-acetylated peptidoglycan of Proteus mirabilis.

Authors:  S Gyorffy; A J Clarke
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

3.  Resistance to infection and activation of the monocyto-macrophage system caused by Bacillus firmus and its fractions.

Authors:  M Mára; J Ocenásková; M Nováková; J Julák; E Mencíková
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

4.  Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus.

Authors:  M E Mulligan; R Y Kwok; D M Citron; J F John; P B Smith
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

5.  The Staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infection.

Authors:  Rosanna Capparelli; Nunzia Nocerino; Chiara Medaglia; Giuseppe Blaiotta; Patrizia Bonelli; Domenico Iannelli
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

6.  Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models.

Authors:  Hiroyoshi Ohsawa; Tadashi Baba; Jumpei Enami; Keiichi Hiramatsu
Journal:  Microbiol Immunol       Date:  2015-04       Impact factor: 1.955

7.  Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.

Authors:  Brandon L Jutras; Robert B Lochhead; Zachary A Kloos; Jacob Biboy; Klemen Strle; Carmen J Booth; Sander K Govers; Joe Gray; Peter Schumann; Waldemar Vollmer; Linda K Bockenstedt; Allen C Steere; Christine Jacobs-Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.